Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)

Clinical trial NCT07347197 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07347197
Sponsor: Heartseed Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Heart Failure Ischemic Heart Failure Ischemic Heart Disease Dilated Cardiomyopathy (DCM)

Start date: 2026-01-01
Primary completion: 2028-01-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.